These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8040015)
1. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Sham J; Choy D; Kwong PW; Cheng AC; Kwong DL; Yau CC; Wan KY; Au GK Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):699-704. PubMed ID: 8040015 [TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma. Huang S; Wang X; Hu C; Ying H Med Oncol; 2013 Dec; 30(4):710. PubMed ID: 23999842 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients. Lin Z; Wang X; Xie W; Yang Z; Che K; Wu VW J Med Imaging Radiat Oncol; 2013 Dec; 57(6):713-8. PubMed ID: 24283561 [TBL] [Abstract][Full Text] [Related]
4. MRI of the hypothalamus and pituitary gland in patients with hyperprolactinaemia following radiotherapy for nasopharyngeal carcinoma. Lau KY; Sze WM; Lee AW; Yau TK; Fung WT; Chan PO Singapore Med J; 2001 Sep; 42(9):406-9. PubMed ID: 11811606 [TBL] [Abstract][Full Text] [Related]
5. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420 [TBL] [Abstract][Full Text] [Related]
6. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma]. Xie GF; Cao KJ; Li Y; Huang PY Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study. Lam KS; Ho JH; Lee AW; Tse VK; Chan PK; Wang C; Ma JT; Yeung RT Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1343-50. PubMed ID: 3624043 [TBL] [Abstract][Full Text] [Related]
8. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma. Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of skull base erosion in nasopharyngeal carcinoma: comparison of plain radiography and computed tomography. Cheung YK; Sham J; Cheung YL; Chan FL Oncology; 1994; 51(1):42-6. PubMed ID: 8265102 [TBL] [Abstract][Full Text] [Related]
10. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Samaan NA; Vieto R; Schultz PN; Maor M; Meoz RT; Sampiere VA; Cangir A; Ried HL; Jesse RH Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1857-67. PubMed ID: 7153098 [TBL] [Abstract][Full Text] [Related]
14. Comments on "Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio". Cheng SH; Jian JJ; Huang AT Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):682-3. PubMed ID: 7726931 [No Abstract] [Full Text] [Related]
15. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques. Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807 [TBL] [Abstract][Full Text] [Related]
16. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system]. Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881 [TBL] [Abstract][Full Text] [Related]
17. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy]. Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966 [TBL] [Abstract][Full Text] [Related]
18. Decreased pituitary gland height after radiation treatment to the hypothalamic-pituitary axis evaluated by MR. Pääkkö E; Talvensaari K; Pyhtinen J; Lanning M AJNR Am J Neuroradiol; 1994 Mar; 15(3):537-41. PubMed ID: 8197954 [TBL] [Abstract][Full Text] [Related]
19. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Pai HH; Thornton A; Katznelson L; Finkelstein DM; Adams JA; Fullerton BC; Loeffler JS; Leibsch NJ; Klibanski A; Munzenrider JE Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1079-92. PubMed ID: 11240250 [TBL] [Abstract][Full Text] [Related]
20. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin. Samaan NA; Bakdash MM; Caderao JB; Cangir A; Jesse RH; Ballantyne AJ Ann Intern Med; 1975 Dec; 83(6):771-7. PubMed ID: 812402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]